31-Aug-2011 - US drug giant Pfizer is to sell its plant in Henrico County, Virginia to Luxembourg-headquartered manufacturer Fareva.
31-Aug-2011 - Vivalis cut its operating loss after demand for its vaccine production cell line drove triple-digit revenue growth.
30-Aug-2011 - Chemicals giant BASF has increased the price of drug APIs and excipients by 10 per cent for the second time in a year.
29-Aug-2011 - Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.
25-Aug-2011 - US chemicals maker Ashland says completion of ISP takeover means simplified supply chains for drug and cosmetics industry customers.
25-Aug-2011 - Irvine Scientific has begun shipping from the cell culture media plant it built to expand into Asia and give clients the security of a second source.
23-Aug-2011 - The USP is strengthening ties to the Brazilian pharmaceutical sector to improve quality and drive harmonisation of standards.
22-Aug-2011 - Contract speciality chemical maker Chemspec International says it will ‘go private’ after being taken over by Halogen Limited, a holding company co-owned by members of its management board.
22-Aug-2011 - in-PharmaTechnologist presents a roundup of recent ingredient and formulation research, including improved API impurity detection and a simple step to boost stability.
18-Aug-2011 - The generic drug industry and the US FDA have reached an agreement that would see the former fund the latter’s overseas facility inspection programme to the tune of $299m a year, according to a number of reports.
18-Aug-2011 - Repligen should consider selling its bioprocessing unit, which sells materials used in mAb production, to make best use of its assets, a shareholder suggests.
18-Aug-2011 - The FDA is prioritising development of technologies to compare biosimilars to innovator products in its plan to modernise regulatory science.
16-Aug-2011 - Surging anti-viral sales drove fine chemical growth at Ampac in Q3, but the unit posted a loss after missing efficiency and throughput targets.
08-Aug-2011 - International Chemical Investors Group (ICIG) will take over Roche’s Colorado API plant in a bid to gain footing in the peptide manufacturing industry.
08-Aug-2011 - The EC has updated stability testing guidance to cover procedures for variations, such as change in batch size, to marketing authorisations.
04-Aug-2011 - The final results of the US FDA, EMA, TGA joint manufacturing facility inspection programme will make for interesting reading for API producers as they strongly hint the approach is here to stay.
04-Aug-2011 - Stellar Biotechnologies is supplying SAFC with an intermediate derived from limpets to support production of cancer vaccines.
04-Aug-2011 - FMC plans to add controlled release technologies and expand excipient production to drive growth at its BioPolymer unit.
03-Aug-2011 - The EDQM will work to improve the quality of traditional Chinese medicines (TCM) sold in Europe under a memorandum of understanding (MoU) with SATCM.
02-Aug-2011 - The EDQM has suggested Google Earth as a potential source of GPS co-ordinate data for manufacturing sites that must be supplied in CEP applications under recently introduced requirements.
28-Jul-2011 - BASF posts Q2 results and says economic uncertainties mean industrial customers are still cautious about placing orders.
27-Jul-2011 - Market analysts PMR have launched a new paper highlighting the potential for API production in Russia, Ukraine and the Baltics.
25-Jul-2011 - India’s CDSCO has issued draft guidance designed to help active pharmaceutical ingredient (API) importers streamline the submission and registration process.
21-Jul-2011 - All strategic suppliers to J&J will need at least two publically-reported sustainability goals under a new initiative by the healthcare giant.
21-Jul-2011 - Lanxess is doubling capacity at a German plant to meet rising demand for menthol, a product used as a pharma excipient and in personal care.